Parnax Lab Limited (BOM:506128)

India flag India · Delayed Price · Currency is INR
111.50
-2.50 (-2.19%)
At close: Jan 20, 2026
-28.50%
Market Cap1.36B
Revenue (ttm)2.05B
Net Income (ttm)110.28M
Shares Out11.49M
EPS (ttm)9.60
PE Ratio12.31
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume6,042
Average Volume5,414
Open111.60
Previous Close114.00
Day's Range105.50 - 113.95
52-Week Range81.00 - 169.65
Beta0.06
RSI47.62
Earnings DateFeb 12, 2026

About Parnax Lab

Parnax Lab Limited engages in the manufacture and export of pharmaceutical formulations in India and internationally. The company offers pharmaceutical products in the form of liquids, ointments, gels, creams, tablets, and capsules; cosmetic products; herbal products; and nutraceutical products. It also provides Oral Formulations, such as cough expectorants, antacids, antihistamines, multi-vitamins, enzyme preparations, pediatric formulations, formulations for geriatrics, highly viscous products, and suspensions. In addition, the company provid... [Read more]

Industry Pharmaceutical Preparations
Founded 1982
Employees 12
Stock Exchange Bombay Stock Exchange
Ticker Symbol 506128
Full Company Profile

Financial Performance

In 2024, Parnax Lab's revenue was 1.88 billion, a decrease of -0.54% compared to the previous year's 1.89 billion. Earnings were 115.19 million, an increase of 19.87%.

Financial Statements